Third Place Award: Reconstruction of metastatic bone loss of the proximal femur and acetabulum: A literature review

Background: Improved rates of long-term survival in cancer patients has led to an increasing prevalence of metastatic disease, notably to osseous structures. The proximal femur and acetabulum are vital weight-bearing surfaces of the lower extremity and common regions of metastatic spread. There are many reconstructive options that depend on several factors including the location of the lesion, type of lesion, and the prognosis of the patient. Methods: An extensive literature review was conducted searching Pubmed.gov with the key words metastatic, proximal femur, acetabulum, reconstruction, and fixation. This identified pathologic characteristics for various metastatic processes, anatomic considerations for the proximal femur, and periacetabular metastatic lesions. This also identified treatment-sensitive tumors compared to treatment-resistant conditions. Reconstruction was usually recommended specifically considering renal, lung, and gastrointestinal carcinomas as well as previously irradiated bone where healing was unlikely. In addition, this study provides a technique guide for implementation of a proximal femoral prosthetic replacement (PFR). Results: The management of femoral head or neck lesions are frequently managed by hemiarthroplasty with overall reasonable outcomes. In intertrochanteric or subtrochanteric regions, there have been high failure rates of intramedullary fixation, and 2-year reoperation rate of up to 35% was reported with conversion to endoprosthesis. In comparison to an 85% implant survival in intramedullary constructions, there was a 100% 5-year survival in endoprosthesis reconstruction. Periacetabular lesions that do not impact structural stability can be managed with palliative measures. Those patients experiencing significant pain with contained defects may be managed with cement augmentation. Support of the columns may be required with fixation into the ilium, and those with extensive disease may require en bloc internal hemipelvectomy. Conclusions: Management of lesions of the proximal femur and acetabulum can be managed with a variety of treatment constructions. The utilization of PFR is increasingly more common especially in the setting of destructive metastatic lesions in the proximal femur as soft-tissue repairs improve ambulatory function. Additionally, the survivorship of endoprosthesis is greater than intramedullary fixation and is recommended for reconstruction for individuals with an expected survivorship greater than 7 mo. Lesions within the periacetabular region that are refractory to nonoperative management may benefit anywhere on the spectrum from intralesional cementation to en bloc hemipelvectomy depending the primary tumor type and degree of osseous involvement. Level of Evidence: Level IV.

[1]  P. Lin,et al.  The Accuracy and Clinical Utility of Intraoperative Frozen Section Analysis in Open Biopsy of Bone , 2019, The Journal of the American Academy of Orthopaedic Surgeons.

[2]  P. Lin,et al.  Is a Cephalomedullary Nail Durable Treatment for Patients With Metastatic Peritrochanteric Disease? , 2018, Clinical orthopaedics and related research.

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  E. Arias,et al.  Deaths: Final Data for 2016. , 2018, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[5]  S. Kliethermes,et al.  No consensus on implant choice for oligometastatic disease of the femoral head and neck , 2018, Journal of bone oncology.

[6]  P. Lin,et al.  Percutaneous cementoplasty with lateral approach under regional anesthesia for acetabulum in patients with bone metastasis , 2018 .

[7]  J. Stevenson,et al.  Hemiarthroplasty proximal femoral endoprostheses following tumour reconstruction: IS ACETABULAR REPLACEMENT NECESSARY? , 2018, The bone & joint journal.

[8]  B. Zacharia,et al.  Skeletal Metastasis—an Epidemiological Study , 2018, Indian Journal of Surgical Oncology.

[9]  Nuno Bonito,et al.  Bone Metastases: An Overview , 2017, Oncology reviews.

[10]  S. Lietman,et al.  Complications With Long Cemented Stems in Proximal Femoral Replacement. , 2016, Orthopedics.

[11]  Neeraj M. Patel,et al.  Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease? , 2016, Clinical orthopaedics and related research.

[12]  B. Erol,et al.  Biomechanical Determination of the Relationship between Femoral Neck Lesion Size and the Risk of Pathological Fracture , 2016, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[13]  I. Adamietz,et al.  Radiotherapy, Bisphosphonates and Surgical Stabilization of Complete or Impending Pathologic Fractures in Patients with Metastatic Bone Disease , 2016, Journal of Cancer.

[14]  B. Snyder,et al.  Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis , 2015, Clinical Cancer Research.

[15]  Zuozhang Yang,et al.  Intramedullary nailing for treatment of pathologic femoral fractures due to metastases. , 2014, Injury.

[16]  N. Magné,et al.  Percutaneous cementoplasty for pelvic bone metastasis , 2000, Supportive Care in Cancer.

[17]  Kevin B. Jones,et al.  Complications of Cemented Long-stem Hip Arthroplasty in Metastatic Bone Disease Revisited , 2013, Clinical orthopaedics and related research.

[18]  L. L. Stern,et al.  Benefits of early intramedullary nailing in femoral metastases , 2013, International Orthopaedics.

[19]  J. Healey,et al.  Endoprosthetic Treatment is More Durable for Pathologic Proximal Femur Fractures , 2012, Clinical orthopaedics and related research.

[20]  E. Ahlmann,et al.  Endoprostheses Last Longer Than Intramedullary Devices in Proximal Femur Metastases , 2012, Clinical orthopaedics and related research.

[21]  R. Lackman,et al.  Bipolar Proximal Femoral Replacement Prostheses for Musculoskeletal Neoplasms , 2007, Clinical orthopaedics and related research.

[22]  F. Frassica,et al.  Proximal femoral replacement for metastatic bone disease. , 2007, Orthopedics.

[23]  R. Coleman Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[24]  R. Randall,et al.  Complications of Cemented Long-stem Hip Arthroplasties in Metastatic Bone Disease , 2006, Clinical orthopaedics and related research.

[25]  R. Wedin,et al.  Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? , 2005, The Journal of bone and joint surgery. British volume.

[26]  W. Mutschler,et al.  Preoperative embolization in spinal and pelvic metastases , 2005, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[27]  W. Ward,et al.  Metastatic Disease of the Femur: Surgical Treatment , 2003, Clinical orthopaedics and related research.

[28]  D. Lester,et al.  Results of a tapered cementless femoral stem implanted in varus. , 2002, The Journal of arthroplasty.

[29]  J. Parvizi,et al.  Thirty-Day Mortality After Elective Total Hip Arthroplasty , 2001, The Journal of bone and joint surgery. American volume.

[30]  A. Aboulafia,et al.  Incidence, location, and diagnostic evaluation of metastatic bone disease. , 2000, The Orthopedic clinics of North America.

[31]  J. Wunder,et al.  Functional and Oncological Outcome of Acetabular Reconstruction for the Treatment of Metastatic Disease* , 2000, The Journal of bone and joint surgery. American volume.

[32]  C. Carrasco,et al.  Preoperative embolization of bone metastases from renal cell carcinoma , 2000, European Radiology.

[33]  E. Lang,et al.  Bone metastases from renal cell carcinoma: preoperative embolization. , 1998, Journal of vascular and interventional radiology : JVIR.

[34]  W. Hayes,et al.  Predicting pathologic fracture risk in the management of metastatic bone defects. , 1995, Clinical orthopaedics and related research.

[35]  H. Mirels Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic Fractures , 1989, Clinical orthopaedics and related research.

[36]  K. Harrington Impending pathologic fractures from metastatic malignancy: evaluation and management. , 1986, Instructional course lectures.

[37]  K. Harrington New trends in the management of lower extremity metastases. , 1982, Clinical orthopaedics and related research.

[38]  K. Harrington The management of acetabular insufficiency secondary to metastatic malignant disease. , 1981, The Journal of bone and joint surgery. American volume.

[39]  J. Murray,et al.  Surgical treatment for secondary neoplastic fractures. A retrospective study of ninety-six patients. , 1970, The Journal of bone and joint surgery. American volume.